MediConnect completes Proof-of-Concept Workflow and begins integration of UK Meds to the MediConnect platform

MediConnect completes Proof-of-Concept Workflow and begins integration of UK Meds to the MediConnect platform
26.09.2019 11:59 am

MediConnect completes Proof-of-Concept Workflow and begins integration of UK Meds to the MediConnect platform


MediConnect (the “Company”), the developer of a framework blockchain solution to trace and manage prescription medication, is pleased to announce that it has completed the workflow for the Proof-of-Concept (“PoC”) and has begun the integration of UK Meds, an online pharmacy and partner of MediConnect, to the MediConnect PoC platform. 

The completed workflow is a significant step forward for MediConnect that establishes a foundation and methodology on which to finalise the PoC, which is designed to track medication through the supply chain from the point at which it is manufactured to its prescription by medical professionals and purchase by patients.  The parameters established as a result of the completed workflow follows rigorous testing from developers and regular consultation with experts in the pharmaceutical industry. 

The experience and knowledge gained during the workflow process will prove invaluable as the Company progresses towards completion of the PoC and a pilot scheme with up to 10 online pharmacies, including UK Meds, in 2020. 

Following the completion of the PoC workflow, MediConnect has commenced the integration of UK Meds to its PoC platform. UK Meds is one of the largest and fastest growing online pharmacies in the UK with a user-base of approximately 400,000 people, issuing 1,000s of prescriptions on the UK Meds website every day. UK Meds current processes will be integrated to the MediConnect solution in one cohesive platform to trace products through its supply chain and prevent the misuse of prescription drugs.

The MediConnect blockchain is being developed by Stratis Group Ltd as a bespoke solution based on the Stratis blockchain. MediConnect has launched its own MEDI Token to handle transactions and transfer value on its platform. The ICO of the MEDI Token is currently live and concludes on 30 September 2019.  

Dexter Blackstock, CEO of MediConnect, commented: “We are delighted to have completed the workflow for the proof-of-concept, an important milestone in MediConnect’s development. The next step is to complete the integration of UK Meds to our proof-of-concept platform and complete a pilot scheme in 2020. The pilot scheme will include up to 10 online pharmacies and bring to life our goal of solving the growing issue of overuse of prescription medication, which will help protect the health of patients while reducing costs for the NHS.” 

Related News

VAKT ecosystem expands commodities inspection services with Intertek

AKT, the company re-imagining commodity post-trade processing underpinned by blockchain, has partnered with leading total quality assurance provider, Intertek, to bring its... Read more »

Lendonomy selects Neonomics to build Norway’s very first PSD2 crowdlending solution

Lendonomy, a Norwegian fintech startup that is developing a blockchain-based “Airbnb for lending” targeting GenZ, and Neonomics, a leading provider of open banking APIs... Read more »

DeeMoney Partners with Ripple to Power Faster and Cheaper Cross-Border Money Transfers

DeeMoney, a fintech company based in Thailand specializing in digital cross-border money transfers, today announced its platform is now... Read more »

Manx Telecom and Minima Complete Successful Blockchain Proof Of Concept To Show Future of Payment

 Minima, the world’s first truly decentralised Blockchain protocol that runs in full on mobile phones, announces the completion of a successful proof of concept with the Isle... Read more »

Free Newsletter Sign-up
+44 (0) 208 819 32 53 +44 (0) 173 261 71 47
Download Our Mobile App
Financial It Youtube channel